These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26363797)

  • 1. IRAS Modulates Opioid Tolerance and Dependence by Regulating μ Opioid Receptor Trafficking.
    Li F; Ma H; Wu N; Li J
    Mol Neurobiol; 2016 Sep; 53(7):4918-30. PubMed ID: 26363797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of agmatine on DAMGO-induced mu-opioid receptor down-regulation and internalization via activation of IRAS, a candidate for imidazoline I(1) receptor.
    Gao Y; Li F; Wu N; Su RB; Liu Y; Lu XQ; Liu Y; Li J
    Eur J Pharmacol; 2008 Dec; 599(1-3):18-23. PubMed ID: 18845140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of IRAS/nischarin (I
    Keller B; La Harpe R; García-Sevilla JA
    Neurochem Int; 2017 Sep; 108():282-286. PubMed ID: 28461172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of agmatine on calcium signal in morphine-dependent CHO cells by activation of IRAS, a candidate for imidazoline I1 receptor.
    Wu N; Su RB; Liu Y; Lu XQ; Zheng JQ; Cong B; Li J
    Eur J Pharmacol; 2006 Oct; 548(1-3):21-8. PubMed ID: 16962578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of IRAS/Nischarin involved in the development of morphine tolerance and physical dependence.
    Li S; Wu N; Zhao TY; Lu GY; Wang ZY; Li F; Li J
    Biochem Biophys Res Commun; 2019 May; 512(3):460-466. PubMed ID: 30902386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsp90β positively regulates μ-opioid receptor function.
    Zhang Y; Zhou P; Wang Z; Chen M; Fu F; Su R
    Life Sci; 2020 Jul; 252():117676. PubMed ID: 32304763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DAMGO-induced μ opioid receptor internalization and recycling restore morphine sensitivity in tolerant rat.
    Ma X; Chen R; Huang M; Wang W; Luo L; Kim DK; Jiang W; Xu T
    Eur J Pharmacol; 2020 Jul; 878():173118. PubMed ID: 32320702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence.
    Xu H; Partilla JS; Wang X; Rutherford JM; Tidgewell K; Prisinzano TE; Bohn LM; Rothman RB
    Synapse; 2007 Mar; 61(3):166-75. PubMed ID: 17152090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependence.
    Jin J; Kittanakom S; Wong V; Reyes BA; Van Bockstaele EJ; Stagljar I; Berrettini W; Levenson R
    BMC Neurosci; 2010 Mar; 11():33. PubMed ID: 20214800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C-mediated inhibition of mu-opioid receptor internalization and its involvement in the development of acute tolerance to peripheral mu-agonist analgesia.
    Ueda H; Inoue M; Matsumoto T
    J Neurosci; 2001 May; 21(9):2967-73. PubMed ID: 11312280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRAS, a candidate for I1-imidazoline receptor, mediates inhibitory effect of agmatine on cellular morphine dependence.
    Wu N; Su RB; Xu B; Lu XQ; Liu Y; Zheng JQ; Piletz JE; Li J; Qin BY
    Biochem Pharmacol; 2005 Oct; 70(7):1079-87. PubMed ID: 16112088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic opioid treatment augments caveolin-1 scaffolding: relevance to stimulatory μ-opioid receptor adenylyl cyclase signaling.
    Chakrabarti S; Chang A; Liu NJ; Gintzler AR
    J Neurochem; 2016 Dec; 139(5):737-747. PubMed ID: 27726130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct association of Mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance.
    Garzón J; Rodríguez-Muñoz M; Sánchez-Blázquez P
    Curr Drug Abuse Rev; 2012 Sep; 5(3):199-226. PubMed ID: 22920535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu opioid receptor mutant, T394A, abolishes opioid-mediated adenylyl cyclase superactivation.
    Wang H; Guang W; Barbier E; Shapiro P; Wang JB
    Neuroreport; 2007 Dec; 18(18):1969-73. PubMed ID: 18007196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular morphine tolerance produced by βarrestin-2-dependent impairment of μ-opioid receptor resensitization.
    Dang VC; Chieng B; Azriel Y; Christie MJ
    J Neurosci; 2011 May; 31(19):7122-30. PubMed ID: 21562274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T394A Mutation at the μ Opioid Receptor Blocks Opioid Tolerance and Increases Vulnerability to Heroin Self-Administration in Mice.
    Wang XF; Barbier E; Chiu YT; He Y; Zhan J; Bi GH; Zhang HY; Feng B; Liu-Chen LY; Wang JB; Xi ZX
    J Neurosci; 2016 Oct; 36(40):10392-10403. PubMed ID: 27707973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu Opioids Induce Biased Signaling at the Full-Length Seven Transmembrane C-Terminal Splice Variants of the mu Opioid Receptor Gene, Oprm1.
    Narayan A; Hunkele A; Xu J; Bassoni DL; Pasternak GW; Pan YX
    Cell Mol Neurobiol; 2021 Jul; 41(5):1059-1074. PubMed ID: 33033993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of Mu-Opioid Receptor Splice Variants and Plasticity of Their Signaling Sequelae to Opioid Analgesic Tolerance.
    Chakrabarti S; Liu NJ; Gintzler AR
    Cell Mol Neurobiol; 2021 Jul; 41(5):855-862. PubMed ID: 32804312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MOR is not enough: identification of novel mu-opioid receptor interacting proteins using traditional and modified membrane yeast two-hybrid screens.
    Petko J; Justice-Bitner S; Jin J; Wong V; Kittanakom S; Ferraro TN; Stagljar I; Levenson R
    PLoS One; 2013; 8(6):e67608. PubMed ID: 23840749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor-
    Puig S; Barker KE; Szott SR; Kann PT; Morris JS; Gutstein HB
    Mol Pharmacol; 2020 Oct; 98(4):487-496. PubMed ID: 32723769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.